E70.2 Disorders of tyrosine metabolism

Name of the Condition

• Disorders of tyrosine metabolism (ICD-10 Code: E70.2)

Summary

Disorders of tyrosine metabolism are rare genetic conditions that disrupt the body's ability to process the amino acid tyrosine. These disorders can lead to the accumulation of toxic metabolites, causing neurological, developmental, and systemic complications. Early detection and management are critical to mitigate long-term effects.

Causes

These disorders are caused by genetic mutations that impair enzymes involved in tyrosine metabolic pathways. The mutations prevent the proper breakdown or conversion of tyrosine, leading to the buildup of harmful substances. Inheritance patterns vary, with some conditions following autosomal recessive or X-linked transmission.

Risk Factors

• Genetic predisposition; family history of metabolic disorders.
• Consanguinity (parents who are close relatives).
• Certain ethnic groups with higher carrier rates for specific mutations.

Symptoms

• Neurological issues, such as developmental delay, intellectual disability, or seizures.
• Behavioral changes, including irritability or hyperactivity.
• Physical symptoms like skin rashes, eczema, or musty body odor.
• Growth retardation or failure to thrive in severe cases.

Diagnosis

Diagnosis typically involves biochemical testing for abnormal tyrosine metabolites in blood or urine. Confirmatory testing may include genetic analysis to identify specific mutations. Newborn screening may detect some forms, though not all.

Treatment Options

Treatment focuses on managing symptoms and reducing metabolite accumulation. This may include dietary modifications (e.g., tyrosine restriction), supplementation with cofactors, or medications to address specific metabolic defects. Regular monitoring of metabolite levels is essential.

Prognosis and Follow-Up

Prognosis varies depending on the specific disorder and timeliness of intervention. Early diagnosis and adherence to treatment can improve outcomes, but some individuals may experience persistent neurological or developmental challenges. Lifelong follow-up with metabolic specialists is recommended.

Complications

• Neurological damage, including intellectual disability or seizures.
• Growth delays or failure to thrive.
• Skin or eye abnormalities (e.g., albinism in some forms).
• Increased risk of organ dysfunction over time.

Lifestyle & Prevention

• Adherence to prescribed dietary restrictions or supplements.
• Regular monitoring of metabolic markers as directed by healthcare providers.
• Genetic counseling for families with a history of tyrosine metabolism disorders.

When to Seek Professional Help

Seek immediate medical attention if symptoms such as seizures, severe developmental regression, or unexplained lethargy occur. Routine follow-up with a metabolic specialist is necessary for ongoing management.

Tips for Medical Coders

Document the specific type of tyrosine metabolism disorder (e.g., tyrosinemia, alkaptonuria) and any associated complications. Ensure clinical documentation supports the diagnosis, including laboratory results or genetic testing when available. Code E70.2 is appropriate for disorders of tyrosine metabolism not classified elsewhere.